During the past decade, Cancer Center of Kansas-Independence conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 210 clinical trials were completed, i.e. on average, 272.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 78 clinical trials were completed. i.e. 557.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Center of Kansas-Independence" #1 sponsor was "National Cancer Institute (NCI)" with 110 trials, followed by "SWOG Cancer Research Network" with 68 trials sponsored, "Alliance for Clinical Trials in Oncology" with 64 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "Eastern Cooperative Oncology Group" with 15 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Center of Kansas-Independence" #1 collaborator was "National Cancer Institute (NCI)" with 187 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "Canadian Cancer Trials Group" with 8 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Center of Kansas-Independence" are "Breast Cancer" (31 trials), "Lymphoma" (17 trials), "Lung Cancer" (14 trials), "Leukemia" (12 trials) and "Colorectal Cancer" (11 trials). Many other conditions were trialed in "Cancer Center of Kansas-Independence" in a lesser frequency.

Most popular intervention types in "Cancer Center of Kansas-Independence" are "Drug" (241 trials), "Other" (170 trials), "Biological" (108 trials), "Procedure" (47 trials) and "Radiation" (36 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (87 trials), "Quality-of-Life Assessment" (45 trials), "Paclitaxel" (30 trials), "placebo" (26 trials) and "Carboplatin" (23 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Center of Kansas-Independence" are 230 trials for "All" genders, 65 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Center of Kansas-Independence". undefined are not yet recruiting, 20 are recruiting, 88 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 160 completed trials in Cancer Center of Kansas-Independence, 1 suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Center of Kansas-Independence, 16 "Phase 1" clinical trials were conducted, 149 "Phase 2" clinical trials and 127 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".